SLC2A1 and keloid: GLUT-1-dependent glycolysis and ROS production mediate the proliferation of keloid fibroblasts, and GLUT-1 inhibitor WZB117 can reduce glycolysis and ROS production of keloid fibroblasts (Lu et al., 2021).